期刊文献+

过表达Sprouty2分子促进HEK293T细胞增殖与存活 被引量:1

Over-expression of human SPRY2 promotes the proliferation and survival of HEK293T cells
下载PDF
导出
摘要 目的构建表达人Sprouty 2(SPRY2)基因的重组表达载体pDC315/hSPRY2,转染人胚肾(HEK)293T细胞表达目的蛋白,初步探讨其对HEK293T细胞增殖与存活的影响。方法构建hSPRY2重组腺病毒表达载体,体外转染HEK293T细胞,以Western blot法检测目的蛋白的表达,以CCK-8法检测SPRY2对HEK293T细胞增殖或去血清条件下细胞存活的影响。结果成功构建重组表达载体pDC315/hSPRY2,在转染的HEK293T细胞中检测到目的蛋白hSPRY2的表达,转染pDC315/hSPRY2组HEK293T细胞的增殖率及存活率均明显高于对照组即转染pDC315/EGFP组(P<0.05)。结论成功构建了hSPRY2重组表达载体,过表达hSPRY2可促进HEK293T细胞的增殖与存活。 Objective To construct a recombinant expression vector pDC315/hSPRY2 carrying human SPRY2 (hSPRY2) gene, and transfect the recombinant plasmid into human embryonic kidney HEK293T cells to express the target protein, and thus explore preliminarily the effect of hSPRY2 on the proliferation and survival of HEK293T cells. Methods The recombinant adenoviral vector expressing hSPRY2 was constructed and transfected into HEK293T cells in v/tro. The expression of hSPRY2 target protein in the transfected cells was identified by Western blot analysis. The effect of hSPRY2 on the proliferation and survival of HEK293T cells in a serum-free condition was tested using CCK-8 assay. Results The recombinant expression vector pDC315/hSPRY2 was constructed, and the target protein hSPRY2 was expressed in the transfected HEK293T cells. The proliferation and survival rates of HEK293T cells transfected with pDC315/hSPRY2 were significantly higher than those transfected with pDC315/EGFP (P 〈 0.05). Conclusion The recombinant expression vector for hSPRY2 was successfully constructed and its expression was demonstrated in the transfected HEK293T cells. Over-expression of SPRY2 promoted the proliferation and survival of HEK293T cells.
出处 《细胞与分子免疫学杂志》 CAS CSCD 北大核心 2014年第5期485-488,共4页 Chinese Journal of Cellular and Molecular Immunology
关键词 人SPRY2 HEK293T细胞 过表达 增殖 存活 human SPRY2 HEK293T cell over-expression proliferation survival
  • 相关文献

参考文献1

二级参考文献30

  • 1Sobin LH,Wittekind CH.TNM classification of malignant tumors,2002.
  • 2El-Serag HB,Rudolph KL.Hepatocellular carcinoma: epidemiology and molecular carcinogenesisGastroenterology,2007.
  • 3Chen X;Cheung S T;So S.Gene expression patterns in human liver cancers,2002(06).
  • 4Tian J;Tang ZY;Ye SL.New human hepatocellular carcinoma (HCC) cell line with highly metastatic potential (MHCC97) and its expressions of the factors associated with metastasis,1999(81).
  • 5Abou-Alfa GK,Schwartz L,Ricci S,Amadori D,Santoro A,Figer A,De Greve J,Douillard JY,Lathia C,Schwartz B,Taylor I,Moscovici M,Saltz LB.Phase II study of sorafenib in patients with advanced hepatocellular carcinoma. Journal of Clinical Oncology . 2006
  • 6Stephen M. Keyse.Dual-specificity MAP kinase phosphatases (MKPs) and cancer[J]. Cancer and Metastasis Reviews . 2008 (2)
  • 7Yong-Qiang Weng,Shuang-Jian Qiu,Yin-Kun Liu,Jia Fan,Qiang Gao,Zhao-You Tang.Down-regulation of β-centractin might be involved in dendritic cells dysfunction and subsequent hepatocellular carcinoma immune escape: a proteomic study[J]. Journal of Cancer Research and Clinical Oncology . 2008 (2)
  • 8Yan Li,Bo Tian,Jiong Yang,Lei Zhao,Xin Wu,Sheng-Long Ye,Yin-Kun Liu,Zhao-You Tang.Stepwise metastatic human hepatocellular carcinoma cell model system with multiple metastatic potentials established through consecutive in vivo selection and studies on metastatic characteristics[J]. Journal of Cancer Research and Clinical Oncology . 2004 (8)
  • 9Y. Li,Z. Tang,S. Ye,B. Liu,Y. Liu,J. Chen,Q. Xue.Establishment of a hepatocellular carcinoma cell line with unique metastatic characteristics through in vivo selection and screening for metastasis-related genes through cDNA microarray[J]. Journal of Cancer Research and Clinical Oncology . 2003 (1)
  • 10Fong CW,Chua MS,McKie AB,Ling SH,Mason V,Li R,et al.Sprouty 2,an inhibitor of mitogen-activated protein kinase signaling,is down-regulated in hepatocellular carcinoma. Cancer Research . 2006

共引文献3

同被引文献4

引证文献1

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部